Sintx Technologies, Inc. (SINT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 350K 700K 1.1M Q3 '21: 239K Q4 '21: 165K Q1 '22: 129K Q2 '22: 240K Q3 '22: 426K Q4 '22: 765K Q1 '23: 539K Q2 '23: 508K Q3 '23: 678K Q4 '23: 902K Q1 '24: 687K Q2 '24: 859K Q3 '24: 799K Q4 '24: 542K Q1 '25: 369K Q2 '25: 151K Q3 '25: 208K Q4 '25: 290K Q1 '26: 380K Q2 '26: 452K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 250K 500K 750K Q3 '21: 49K Q4 '21: 40K Q1 '22: 49K Q2 '22: 174K Q3 '22: 337K Q4 '22: 735K Q1 '23: 421K Q2 '23: 404K Q3 '23: 561K Q4 '23: 457K Q1 '24: 464K Q2 '24: 635K Q3 '24: 589K Q4 '24: 388K Q1 '25: 123K Q2 '25: 57K Q3 '25: 93K Q4 '25: 188K Q1 '26: 144K Q2 '26: 278K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -2.8M Q4 '21: -2.6M Q1 '22: -2.9M Q2 '22: -2.8M Q3 '22: -2.8M Q4 '22: -2.9M Q1 '23: -3.6M Q2 '23: -3.5M Q3 '23: -3.6M Q4 '23: -2.7M Q1 '24: -3.2M Q2 '24: -2.7M Q3 '24: -6.4M Q4 '24: -1.7M Q1 '25: -2.4M Q2 '25: -2.7M Q3 '25: -3.4M Q4 '25: -2.3M Q1 '26: -3.2M Q2 '26: -2.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -2.3M Q4 '21: -2.1M Q1 '22: -2.8M Q2 '22: -2.5M Q3 '22: -2.7M Q4 '22: -4M Q1 '23: -293K Q2 '23: -2.5M Q3 '23: -3.2M Q4 '23: -2.3M Q1 '24: -886K Q2 '24: -2.2M Q3 '24: -6.2M Q4 '24: -1.7M Q1 '25: -2.3M Q2 '25: -2.3M Q3 '25: -3.5M Q4 '25: -2.2M Q1 '26: -2.8M Q2 '26: -2.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 200K 400K 600K Q3 '21: 190K Q4 '21: 125K Q1 '22: 80K Q2 '22: 66K Q3 '22: 89K Q4 '22: 30K Q1 '23: 118K Q2 '23: 104K Q3 '23: 117K Q4 '23: 445K Q1 '24: 223K Q2 '24: 224K Q3 '24: 210K Q4 '24: 154K Q1 '25: 246K Q2 '25: 94K Q3 '25: 115K Q4 '25: 102K Q1 '26: 236K Q2 '26: 174K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: -2.4M Q4 '21: -2.4M Q1 '22: -3.2M Q2 '22: -2.5M Q3 '22: -2.5M Q4 '22: -2.1M Q1 '23: -4.9M Q2 '23: -3.2M Q3 '23: -2.9M Q4 '23: -3.1M Q1 '24: -2.7M Q2 '24: -2.2M Q3 '24: -2.6M Q4 '24: -1.1M Q1 '25: -1.3M Q2 '25: -2.4M Q3 '25: -2.5M Q4 '25: -2.3M Q1 '26: -2.5M Q2 '26: -2.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: -5M Q4 '21: -2.9M Q1 '22: -3.4M Q2 '22: -2.9M Q3 '22: -3M Q4 '22: -2.4M Q1 '23: -5.1M Q2 '23: -3.3M Q3 '23: -3M Q4 '23: -3.2M Q1 '24: -2.9M Q2 '24: -2.6M Q3 '24: -2.6M Q4 '24: -1.3M Q1 '25: -1.4M Q2 '25: -2.4M Q3 '25: -2.6M Q4 '25: -2.4M Q1 '26: -2.5M Q2 '26: -2.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q1 '20: 8M Q2 '20: 12.1M Q3 '20: 22.8M Q1 '21: 24.7M Q2 '21: 24.7M Q3 '21: 25.1M Q1 '22: 247.1K Q2 '22: 250.8K Q3 '22: 250.9K Q1 '23: 2.6M Q2 '23: 22.2K Q3 '23: 22K Q1 '24: 172.3K Q2 '24: 697.9K Q3 '24: 897.3K Q1 '25: 1.8M Q2 '25: 2.5M Q3 '25: 3M Q1 '26: 4M Q2 '26: 4.8M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-75.00 -50.00 -25.00 0.00 25.00 50.00 75.00 Q4 '14: -39.98 Q1 '15: -42.19 Q2 '15: -42.76 Q3 '15: -68.95 Q4 '16: -13.63 Q1 '17: -10.18 Q2 '17: -5.98 Q3 '17: -0.69 Q4 '17: -3.08 Q1 '18: -3.99 Q1 '21: 0.34 Q2 '21: 0.60 Q3 '21: 0.60 Q4 '21: -39.93 Q1 '25: 5.18 Q2 '25: 7.88 Q3 '25: 11.38 Q4 '25: -5.65 Q1 '26: -5.06 Q2 '26: -4.90 Q1 '15 Q4 '16 Q3 '17 Q1 '21 Q4 '21 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.